| Code | Description | Claims | Beneficiaries | Total Paid |
| 96361 |
Intravenous infusion, hydration; each additional hour |
17,775 |
13,563 |
$5.56M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
38,544 |
34,930 |
$5.33M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
44,044 |
39,880 |
$4.97M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
15,037 |
12,892 |
$2.04M |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,525 |
4,632 |
$1.32M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,185 |
4,391 |
$1.25M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,040 |
3,383 |
$1.04M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,857 |
4,502 |
$617K |
| 59025 |
Fetal non-stress test |
3,907 |
2,820 |
$596K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,535 |
2,230 |
$552K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
5,120 |
4,173 |
$497K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,027 |
3,154 |
$463K |
| G0378 |
Hospital observation service, per hour |
5,301 |
2,712 |
$390K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,055 |
2,766 |
$387K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,425 |
1,158 |
$362K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,825 |
2,313 |
$331K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,843 |
1,093 |
$285K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
56,706 |
48,694 |
$247K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,846 |
5,272 |
$210K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
12,756 |
11,302 |
$205K |
| 20553 |
|
1,381 |
1,210 |
$150K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
852 |
749 |
$141K |
| 76642 |
|
1,087 |
1,028 |
$135K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,867 |
813 |
$117K |
| 70496 |
|
578 |
486 |
$115K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,413 |
1,225 |
$107K |
| 76830 |
Ultrasound, transvaginal |
1,387 |
1,223 |
$102K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
892 |
798 |
$97K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,083 |
1,978 |
$95K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
899 |
714 |
$94K |
| 93356 |
|
402 |
359 |
$94K |
| 47562 |
|
42 |
30 |
$84K |
| 12001 |
|
527 |
488 |
$82K |
| 93971 |
|
1,220 |
1,051 |
$77K |
| 20610 |
|
563 |
316 |
$74K |
| 72131 |
|
1,377 |
1,142 |
$70K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,864 |
4,726 |
$66K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
256 |
233 |
$57K |
| 71250 |
|
781 |
677 |
$55K |
| 93970 |
|
448 |
408 |
$54K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
138 |
113 |
$53K |
| 71045 |
Radiologic examination, chest; single view |
18,297 |
15,847 |
$51K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
67,172 |
55,665 |
$49K |
| 10060 |
|
289 |
261 |
$47K |
| 71046 |
Radiologic examination, chest; 2 views |
3,193 |
2,912 |
$46K |
| 82805 |
|
1,940 |
1,454 |
$46K |
| 70491 |
|
156 |
142 |
$45K |
| 80053 |
Comprehensive metabolic panel |
5,362 |
4,389 |
$40K |
| 97165 |
|
673 |
550 |
$38K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
27,706 |
23,885 |
$38K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,285 |
1,906 |
$35K |
| 97162 |
|
988 |
753 |
$35K |
| 36415 |
Collection of venous blood by venipuncture |
16,880 |
11,610 |
$34K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
152 |
121 |
$31K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
25,255 |
21,314 |
$31K |
| 96367 |
|
867 |
619 |
$31K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,969 |
1,760 |
$30K |
| 84484 |
|
21,333 |
12,268 |
$30K |
| 76536 |
|
253 |
231 |
$27K |
| 73130 |
|
1,734 |
1,513 |
$27K |
| 93017 |
|
338 |
294 |
$27K |
| 86780 |
|
899 |
833 |
$26K |
| 77065 |
Tomosynthesis, mammo |
737 |
624 |
$26K |
| 73562 |
|
1,017 |
865 |
$25K |
| 97161 |
|
399 |
321 |
$25K |
| 73030 |
|
1,614 |
1,375 |
$24K |
| 97166 |
|
750 |
559 |
$24K |
| 87529 |
|
3,132 |
1,709 |
$23K |
| 80076 |
|
17,982 |
15,362 |
$23K |
| J3490 |
Unclassified drugs |
6,706 |
4,491 |
$23K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,574 |
3,873 |
$23K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
151 |
142 |
$22K |
| 86850 |
|
1,002 |
843 |
$22K |
| 77066 |
Tomosynthesis, mammo |
628 |
577 |
$21K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
758 |
647 |
$21K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,965 |
2,594 |
$20K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,182 |
2,083 |
$19K |
| 12011 |
|
117 |
108 |
$18K |
| 86900 |
|
1,322 |
1,122 |
$18K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
149 |
133 |
$18K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
101 |
91 |
$17K |
| 19083 |
|
27 |
24 |
$17K |
| P9045 |
Infusion, albumin (human), 5%, 250 ml |
125 |
91 |
$17K |
| 73630 |
|
1,998 |
1,751 |
$17K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
145 |
117 |
$16K |
| 90715 |
|
1,119 |
937 |
$16K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,969 |
1,760 |
$16K |
| 94010 |
|
227 |
204 |
$15K |
| 80069 |
|
2,629 |
1,366 |
$15K |
| 72100 |
|
659 |
590 |
$15K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
15,175 |
13,433 |
$15K |
| 70486 |
|
599 |
506 |
$14K |
| 99152 |
|
555 |
520 |
$14K |
| 12002 |
|
99 |
85 |
$14K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
581 |
518 |
$13K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,891 |
1,696 |
$13K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
11,890 |
8,761 |
$13K |
| 80061 |
Lipid panel |
1,149 |
1,033 |
$12K |
| 94726 |
|
185 |
167 |
$12K |
| 72128 |
|
619 |
495 |
$12K |
| 74018 |
|
701 |
624 |
$11K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,140 |
955 |
$11K |
| 73110 |
|
948 |
850 |
$11K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
17,322 |
13,890 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,355 |
1,147 |
$10K |
| 76870 |
|
140 |
122 |
$10K |
| 73610 |
|
1,619 |
1,445 |
$10K |
| 84702 |
|
1,597 |
1,244 |
$10K |
| 62323 |
|
35 |
29 |
$10K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
990 |
912 |
$10K |
| 86803 |
|
472 |
430 |
$10K |
| 72132 |
|
114 |
94 |
$9K |
| 81001 |
|
25,673 |
22,400 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
6,292 |
5,645 |
$9K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
780 |
621 |
$9K |
| 84439 |
|
792 |
705 |
$9K |
| 73502 |
|
725 |
638 |
$9K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
332 |
296 |
$9K |
| 73560 |
|
1,167 |
969 |
$9K |
| 74420 |
|
81 |
53 |
$8K |
| 82607 |
|
595 |
513 |
$8K |
| 85027 |
|
2,655 |
2,091 |
$8K |
| 64999 |
|
104 |
80 |
$8K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
279 |
122 |
$7K |
| 70498 |
|
583 |
491 |
$7K |
| 94729 |
|
187 |
169 |
$7K |
| 72040 |
|
172 |
150 |
$6K |
| 82728 |
|
518 |
438 |
$6K |
| 83735 |
|
4,934 |
3,530 |
$6K |
| 74183 |
|
27 |
24 |
$6K |
| 83880 |
|
2,097 |
1,670 |
$5K |
| 72141 |
|
27 |
24 |
$5K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
12 |
12 |
$5K |
| 86901 |
|
1,322 |
1,123 |
$5K |
| 96376 |
|
3,300 |
1,919 |
$5K |
| 88307 |
|
45 |
36 |
$4K |
| 83690 |
|
15,644 |
13,314 |
$4K |
| 73700 |
|
63 |
52 |
$4K |
| 96368 |
|
231 |
168 |
$4K |
| 87340 |
|
289 |
253 |
$4K |
| 85610 |
|
3,308 |
2,467 |
$4K |
| 86762 |
|
182 |
159 |
$4K |
| 73080 |
|
508 |
461 |
$4K |
| 81025 |
|
11,538 |
10,155 |
$4K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
289 |
148 |
$4K |
| 83540 |
|
537 |
455 |
$4K |
| 76775 |
|
56 |
52 |
$4K |
| 88341 |
|
82 |
38 |
$4K |
| 97116 |
|
132 |
57 |
$4K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
14 |
13 |
$4K |
| 87077 |
|
1,863 |
1,445 |
$3K |
| 97535 |
Self-care/home management training, each 15 minutes |
150 |
68 |
$3K |
| 73590 |
|
625 |
534 |
$3K |
| 73140 |
|
259 |
233 |
$3K |
| 83550 |
|
520 |
440 |
$3K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
228 |
203 |
$3K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
12 |
12 |
$3K |
| 64488 |
|
20 |
13 |
$3K |
| 84112 |
|
61 |
56 |
$3K |
| 82950 |
|
183 |
172 |
$3K |
| 94667 |
|
94 |
84 |
$3K |
| 01999 |
|
374 |
326 |
$3K |
| 29125 |
|
700 |
630 |
$3K |
| 87634 |
|
905 |
822 |
$2K |
| 87081 |
|
104 |
93 |
$2K |
| 73090 |
|
435 |
382 |
$2K |
| 71271 |
|
14 |
14 |
$2K |
| 85378 |
|
2,682 |
2,298 |
$2K |
| J7999 |
Compounded drug, not otherwise classified |
2,493 |
1,962 |
$2K |
| 82746 |
|
481 |
405 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,721 |
1,826 |
$2K |
| 80320 |
|
200 |
165 |
$2K |
| 81003 |
|
4,545 |
3,918 |
$2K |
| J2800 |
Injection, methocarbamol, up to 10 ml |
670 |
535 |
$2K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
749 |
407 |
$2K |
| 87186 |
|
1,524 |
1,181 |
$2K |
| 83605 |
|
3,150 |
2,149 |
$2K |
| 92610 |
|
84 |
58 |
$2K |
| 71101 |
|
412 |
359 |
$2K |
| 76801 |
|
41 |
40 |
$1K |
| 93880 |
|
16 |
13 |
$1K |
| 84100 |
|
740 |
466 |
$1K |
| 82575 |
|
182 |
136 |
$1K |
| 87210 |
|
1,139 |
1,021 |
$1K |
| 84145 |
|
1,831 |
1,459 |
$1K |
| 85651 |
|
821 |
704 |
$1K |
| 85007 |
|
1,335 |
1,072 |
$1K |
| 85014 |
|
314 |
222 |
$1K |
| 72110 |
|
26 |
25 |
$1K |
| 77080 |
|
16 |
13 |
$1K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,686 |
674 |
$966.20 |
| 77002 |
|
1,167 |
986 |
$956.74 |
| 82248 |
|
360 |
265 |
$948.85 |
| 87040 |
|
2,915 |
1,310 |
$943.28 |
| 00840 |
|
184 |
127 |
$928.00 |
| 85018 |
|
475 |
308 |
$859.21 |
| 86140 |
|
100 |
85 |
$739.09 |
| 82550 |
|
797 |
621 |
$739.07 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,206 |
869 |
$734.71 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,678 |
1,251 |
$706.29 |
| 87070 |
|
192 |
153 |
$699.31 |
| 86141 |
|
288 |
241 |
$658.99 |
| 84156 |
|
200 |
152 |
$647.47 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15,954 |
13,420 |
$638.03 |
| 86703 |
|
41 |
38 |
$605.50 |
| G0008 |
Administration of influenza virus vaccine |
52 |
34 |
$601.12 |
| 73552 |
|
163 |
129 |
$599.92 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,017 |
2,253 |
$593.11 |
| 84132 |
|
654 |
485 |
$527.82 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
8,298 |
6,922 |
$418.54 |
| 82330 |
|
278 |
174 |
$415.92 |
| 82140 |
|
328 |
250 |
$407.59 |
| 90686 |
|
23 |
14 |
$380.81 |
| 72170 |
|
164 |
127 |
$361.80 |
| 73620 |
|
13 |
13 |
$359.43 |
| 85730 |
|
847 |
706 |
$349.88 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
521 |
406 |
$348.87 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
929 |
707 |
$346.75 |
| 82043 |
|
66 |
60 |
$337.41 |
| 73564 |
|
12 |
12 |
$335.41 |
| 82105 |
|
12 |
12 |
$313.18 |
| 84703 |
|
677 |
602 |
$308.50 |
| 72072 |
|
15 |
13 |
$276.14 |
| 86308 |
|
142 |
118 |
$273.87 |
| 82947 |
|
22 |
13 |
$269.12 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
15,791 |
12,609 |
$257.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
762 |
639 |
$249.46 |
| 84550 |
|
73 |
62 |
$243.93 |
| J1805 |
Injection, esmolol hydrochloride, 10 mg |
81 |
69 |
$236.41 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,468 |
5,266 |
$233.23 |
| J1953 |
Injection, levetiracetam, 10 mg |
43 |
24 |
$217.24 |
| 88342 |
|
364 |
274 |
$205.59 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
6,962 |
5,046 |
$171.35 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
486 |
291 |
$167.58 |
| 86592 |
|
14 |
14 |
$162.56 |
| 82010 |
|
637 |
509 |
$158.69 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,441 |
616 |
$156.49 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
173 |
143 |
$140.22 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,428 |
1,888 |
$137.20 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
51 |
36 |
$136.34 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
73 |
63 |
$135.88 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,096 |
819 |
$128.61 |
| 85049 |
|
155 |
98 |
$122.17 |
| J2060 |
Injection, lorazepam, 2 mg |
781 |
544 |
$114.77 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,348 |
1,584 |
$113.74 |
| 82570 |
|
16 |
14 |
$110.19 |
| 87205 |
|
244 |
179 |
$107.51 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
785 |
657 |
$99.93 |
| J3360 |
Injection, diazepam, up to 5 mg |
212 |
115 |
$96.33 |
| J1790 |
Injection, droperidol, up to 5 mg |
862 |
677 |
$77.74 |
| J0592 |
Injection, buprenorphine hydrochloride, 0.1 mg |
444 |
358 |
$75.25 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
664 |
440 |
$64.27 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,027 |
840 |
$59.68 |
| J2704 |
Injection, propofol, 10 mg |
998 |
769 |
$57.76 |
| 73060 |
|
15 |
14 |
$54.81 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
1,089 |
1,027 |
$40.25 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
785 |
605 |
$38.23 |
| J1630 |
Injection, haloperidol, up to 5 mg |
174 |
129 |
$26.95 |
| J1940 |
Injection, furosemide, up to 20 mg |
286 |
181 |
$25.88 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
157 |
109 |
$25.32 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
59 |
55 |
$23.48 |
| J3480 |
Injection, potassium chloride, per 2 meq |
552 |
399 |
$22.79 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
43 |
43 |
$18.52 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
965 |
651 |
$16.08 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
750 |
553 |
$13.98 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
22 |
13 |
$8.68 |
| 51702 |
|
33 |
26 |
$8.20 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
163 |
129 |
$6.65 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
461 |
417 |
$6.45 |
| J3411 |
Injection, thiamine hcl, 100 mg |
23 |
12 |
$5.44 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
144 |
96 |
$4.57 |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
320 |
223 |
$1.72 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
446 |
349 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
53 |
42 |
$0.00 |
| C1758 |
Catheter, ureteral |
124 |
93 |
$0.00 |
| 00300 |
|
26 |
24 |
$0.00 |
| 72129 |
|
19 |
13 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
260 |
202 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
141 |
95 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
59 |
41 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
24 |
14 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
38 |
36 |
$0.00 |
| 00910 |
|
22 |
15 |
$0.00 |
| 15853 |
|
27 |
26 |
$0.00 |
| 85347 |
|
21 |
13 |
$0.00 |
| C1769 |
Guide wire |
690 |
525 |
$0.00 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
56 |
37 |
$0.00 |
| A4648 |
Tissue marker, implantable, any type, each |
258 |
222 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
142 |
117 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
171 |
141 |
$0.00 |
| 88304 |
|
563 |
453 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
311 |
208 |
$0.00 |
| 94760 |
|
432 |
358 |
$0.00 |
| J0613 |
Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg |
24 |
13 |
$0.00 |
| 94761 |
|
14 |
12 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
68 |
53 |
$0.00 |
| 00790 |
|
34 |
26 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
12 |
12 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
14 |
12 |
$0.00 |
| J0456 |
Injection, azithromycin, 500 mg |
13 |
12 |
$0.00 |